12.33

3.79% -0.48

Novocure Ltd (NVCR)

Panoramica Notizia Cronologia dei prezzi Catena di opzioni Financials Perché NVCR Giù? Forum Previsione

Precedente Chiudi:

$12.81

Aprire:

$12.8

Volume 24 ore:

1.11M

Relative Volume:

0.71

Capitalizzazione di mercato:

$1.38B

Reddito:

$577.74M

Utile/perdita netta:

$-149.78M

Rapporto P/E:

-8.8071

EPS:

-1.4

Flusso di cassa netto:

$-78.21M

1 W Prestazione:

-9.24%

1M Prestazione:

-15.93%

6M Prestazione:

-32.09%

1 anno Prestazione:

-23.83%

Intervallo 1D:

$12.19

$12.80

Intervallo di 1 settimana:

$12.19

$14.22

Portata 52W:

$10.87

$34.13

Novocure Ltd Stock (NVCR) Company Profile

Nome

Novocure Ltd

Settore

Healthcare (1139)

Industria

Medical Devices (144)

Telefono

44 (0)15 3475 6700

Indirizzo

NO. 4 THE FORUM, ST. HELIER

Dipendente

1,488

Cinguettio

@novocure

Prossima data di guadagno

2024-10-30

Ultimi documenti SEC

NVCR's Discussions on Twitter

Confronta NVCR con altri titoli

Azioni	Prezzo	Cap. di mercato	Reddito	Reddito netto	Flusso di cassa	EPS
NVCR Novocure Ltd	12.33	1.43B	577.74M	-149.78M	-78.21M	-1.40
ABT Abbott Laboratories	123.81	214.96B	43.84B	13.90B	6.92B	7.9725
BSX Boston Scientific Corp	98.94	149.24B	19.35B	2.78B	3.49B	1.8696
SYK Stryker Corp	359.50	136.23B	24.38B	2.94B	4.02B	7.6145
MDT Medtronic Plc	89.81	116.33B	34.20B	4.69B	5.30B	3.6218
EW Edwards Lifesciences Corp	83.14	48.41B	5.88B	1.34B	577.90M	2.3455

Novocure Ltd Stock (NVCR) Upgrades & Downgrades

Data	Azione	Analista	Modifica della valutazione
2025-07-25	Downgrade	Wells Fargo	Overweight → Equal Weight
2025-07-08	Iniziato	Ladenburg Thalmann	Buy
2024-12-02	Aggiornamento	Evercore ISI	In-line → Outperform
2024-10-16	Aggiornamento	H.C. Wainwright	Neutral → Buy
2023-11-20	Ripresa	JP Morgan	Neutral
2023-08-28	Downgrade	H.C. Wainwright	Buy → Neutral
2023-08-08	Aggiornamento	Piper Sandler	Neutral → Overweight
2023-08-04	Iniziato	SVB Securities	Outperform
2023-07-31	Aggiornamento	Evercore ISI	Underperform → In-line
2023-06-07	Aggiornamento	Wedbush	Underperform → Neutral
2023-05-16	Aggiornamento	Wells Fargo	Equal Weight → Overweight
2023-03-17	Downgrade	JP Morgan	Neutral → Underweight
2023-01-06	Downgrade	Wells Fargo	Overweight → Equal Weight
2023-01-05	Reiterato	H.C. Wainwright	Buy
2022-11-29	Aggiornamento	Wells Fargo	Equal Weight → Overweight
2022-10-24	Downgrade	Piper Sandler	Overweight → Neutral
2022-07-05	Downgrade	Evercore ISI	In-line → Underperform
2022-05-16	Iniziato	H.C. Wainwright	Buy
2022-02-08	Iniziato	Loop Capital	Buy
2022-02-02	Aggiornamento	Oppenheimer	Perform → Outperform
2022-01-20	Aggiornamento	Truist	Hold → Buy
2022-01-03	Aggiornamento	Evercore ISI	Underperform → In-line
2021-07-01	Downgrade	Mizuho	Buy → Neutral
2021-04-14	Downgrade	Wedbush	Neutral → Underperform
2021-01-25	Reiterato	Piper Sandler	Overweight
2020-09-23	Iniziato	Northland Capital	Outperform
2020-09-18	Downgrade	Wells Fargo	Overweight → Equal Weight
2020-09-17	Downgrade	Truist	Buy → Hold
2020-06-01	Ripresa	Oppenheimer	Perform
2020-05-01	Downgrade	Oppenheimer	Outperform → Perform
2020-04-09	Downgrade	Evercore ISI	In-line → Underperform
2020-03-05	Aggiornamento	Wells Fargo	Equal Weight → Overweight
2020-01-02	Downgrade	Evercore ISI	Outperform → In-line
2019-07-29	Aggiornamento	SunTrust	Hold → Buy
2019-07-26	Downgrade	JP Morgan	Overweight → Neutral
2019-07-26	Downgrade	Wedbush	Outperform → Neutral
2019-03-20	Iniziato	SunTrust	Hold
2018-11-02	Downgrade	Wells Fargo	Outperform → Market Perform
2018-07-16	Iniziato	Evercore ISI	Outperform
2018-04-18	Reiterato	Mizuho	Buy
2018-02-23	Reiterato	Mizuho	Buy
2017-05-24	Aggiornamento	Wells Fargo	Market Perform → Outperform
2016-07-29	Reiterato	Wedbush	Outperform
2016-01-19	Iniziato	Barclays	Underweight
2015-12-02	Iniziato	Deutsche Bank	Hold

Mostra tutto

Novocure Ltd Borsa (NVCR) Ultime notizie

12:32 PM

NovoCure (NVCR) Is Down 5.7% After Q3 Revenue Growth and Expanded International Coverage — Has the Growth Story Changed? - simplywall.st

12:32 PM

01:29 AM

HC Wainwright Increases Earnings Estimates for NovoCure - MarketBeat

01:29 AM

Nov 02, 2025

Chart overlay techniques for tracking NovoCure LimitedQuarterly Trade Summary & Free Safe Entry Trade Signal Reports - newser.com

Nov 02, 2025

Is NovoCure Limited stock attractive for hedge fundsGDP Growth & Pattern Based Trade Signal System - newser.com

Nov 02, 2025

Is NovoCure Limited stock oversold or undervaluedGap Up & Weekly Momentum Stock Picks - newser.com

Nov 02, 2025

NovoCure Limited (NASDAQ:NVCR) Receives Average Recommendation of "Hold" from Analysts - MarketBeat

Nov 02, 2025

NovoCure Limited (NASDAQ:NVCR) Q3 2025 Earnings Call Transcript - Insider Monkey

Nov 02, 2025

Nov 01, 2025

How interest rate cuts could boost NovoCure Limited stockJuly 2025 Opening Moves & Verified Chart Pattern Signals - newser.com

Nov 01, 2025

What does recent volatility data suggest for NovoCure LimitedJuly 2025 Reactions & Consistent Profit Trade Alerts - newser.com

Nov 01, 2025

Oct 31, 2025

NovoCure’s Mixed Q3: Growth Amid Challenges - TipRanks

Oct 31, 2025

NovoCure (NVCR): Losses Worsen, Testing Bullish Narrative on Valuation and Growth Potential - simplywall.st

Oct 31, 2025

Novocure Ltd earnings beat by $0.09, revenue topped estimates - Investing.com UK

Oct 31, 2025

Emerald Mutual Fund Advisers Trust Reduces Position in NovoCure Limited $NVCR - MarketBeat

Oct 31, 2025

NovoCure Expands Global Reach Within Nasdaq Today Trends - Kalkine Media

Oct 31, 2025

Novocure Ltd. Reports Q3 2025 Financial Results - TipRanks

Oct 31, 2025

Order flow analysis tools used on NovoCure Limited2025 Top Decliners & AI Driven Price Predictions - newser.com

Oct 31, 2025

Decoding NovoCure Ltd (NVCR): A Strategic SWOT Insight - GuruFocus

Oct 31, 2025

Oct 30, 2025

HC Wainwright & Co. Raises PT for NVCR, Maintains Buy Rating | N - GuruFocus

Oct 30, 2025

Assessing NovoCure (NVCR) Valuation as Investors Revisit Recovery Potential - simplywall.st

Oct 30, 2025